Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript November 7, 2024Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:IRWD’
8 Penny Stocks with Biggest Upside Potential According to Analysts
The Federal Reserve slashed interest rates by a half point in September, kickstarting its first easing campaign in four years.
10 Best Multibagger Penny Stocks of 2025
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name, Celine, and I will be your conference operator today.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.
Top 5 Extreme Value Stocks To Buy
In this article, we discuss the top 5 extreme value stocks to buy.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Sharell and I will be your conference operator today.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q1 2023 Investor Update Conference Call. Today's call is being recorded [Operator Instructions].
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the Ironwood Pharmaceuticals Q4 and Full Year 2022 Investor Update Conference Call. Today's call is being recorded. . Thank you.
5 Small Innovative Companies According to the Media
In this piece, we will take a look at the five small innovative companies according to the media.
12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued pharma stocks to buy according to hedge funds.
5 Best Low Price Pharma Stocks To Buy Now
Haleon plc (NYSE:HLN) was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
10 Cheap Pharmaceutical Stocks For 2022
In this article, we discuss 10 cheap pharmaceutical stocks for 2022.
Here is What Hedge Funds Think About Ironwood Pharmaceuticals, Inc. (IRWD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
5 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 5 growth stocks under $20 in billionaire Ken Fisher's portfolio.
Hedge Fund Sentiment Is Stagnant On Ironwood Pharmaceuticals, Inc. (IRWD)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
10 Best Stocks Under $15 According to Billionaire Michael Price
In this article, we will take a look at the 10 best stocks under $15 according to Billionaire Michael Price.
5 Cheap Pharmaceutical Stocks to Watch
In this article, we discuss the 5 cheap pharmaceutical stocks to watch.
Is Ironwood Pharmaceuticals, Inc. (IRWD) A Good Stock To Buy?
Is Ironwood Pharmaceuticals, Inc.
Is IRWD Stock A Buy or Sell?
In this article we will take a look at whether hedge funds think Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is a good investment right now.
Hedge Funds Getting More Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Make The Right Call On Ironwood Pharmaceuticals, Inc. (IRWD) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Still Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Have Never Been This Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
We hate to say this but, we told you so.
Here’s What Hedge Funds Think About Ironwood Pharmaceuticals, Inc. (IRWD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Ditched Ironwood Pharmaceuticals, Inc. (IRWD) At The Right Time
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Hedge Funds Have Never Been This Bullish On Ironwood Pharmaceuticals, Inc. (IRWD)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and optimism towards the resolution of...
Did Hedge Funds Drop The Ball On Ironwood Pharmaceuticals, Inc. (IRWD) ?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Hedge Funds Are Betting On Ironwood Pharmaceuticals, Inc. (IRWD)
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Sarissa Capital’s Alex Denner Bullish on Biogen (BIIB)
Sarissa Capital Management is a Greenwich, Connecticut-based activist hedge fund established in 2012 by its current chief investment officer, Dr.
Don’t Miss Out On These Tantalizing Sohn Conference Stock Pitches
The Sohn and Next Wave Sohn Conferences took place in San Francisco last week, shining the spotlight on several growing and established hedge funds, who shared some of their best...
Ironwood Pharmaceuticals, Inc. (IRWD) Has A Near Term Catalyst To Watch
Ironwood Pharmaceuticals, Inc.
Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks...
Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
What’s the Deal With These 5 Tanking Stocks?
With several major tech companies due to report earnings in the coming days, the NASDAQ and S&P 500 are strangely quiet.
Be Wary of These Five Tanking Stocks Today, Office Depot Among Them
Although all three indexes are well in the green and the Dow Jones is above 18,000 with this quarter's earnings season being relatively quiet and the results less dire than had...
Redmile Group’s Top Q4 Moves as Its Long Positions Show Gains of 20% in 2015
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector.
Four Fresh Moves Disclosed by Two Top Performing Hedge Funds
The hedge fund industry had a disappointing 2015 in terms of returns, so numerous money managers may face increasing redemption requests should their performance continue to disappoint...
Steve Cohen Discloses 5.0% Stake In Ironwood Pharmaceuticals Inc. (IRWD)
Steve Cohen’s Point72 Asset Management has disclosed a 6.39 million share passive stake in Ironwood Pharmaceuticals Inc.
One Of Mark Lampert’s Small-Cap Biotech Picks Has Returned 84% This Year And It’s Not Done Yet
Mark Lampert’s Biotechnology Value Fund recently filed its 13F with the U.S. Securities and Exchange Commission for the reporting period of March 31.
Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)
In the 21st century investor’s toolkit, there are plenty of indicators market participants can use to analyze their holdings.
Johnson & Johnson (JNJ), Forest Laboratories, Inc. (FRX), Pfizer Inc. (PFE): Pharmas Spending the Most to Catch Your Doctor’s Eye
Pharmaceutical firms spend a lot of money to influence physicians to prescribe their products.
WuXi PharmaTech (Cayman) Inc. (ADR) (WX): Are Hedge Funds Right About This Stock?
In the eyes of many of your fellow readers, hedge funds are perceived as useless, old investment vehicles of an era lost to time.
ICON plc – Ordinary Shares (ICLR): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
To many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Do Hedge Funds and Insiders Love PAREXEL International Corporation (PRXL)?
In the financial world, there are plenty of metrics shareholders can use to track their holdings. Some of the most under-the-radar are hedge fund and insider trading activity.
Do Hedge Funds and Insiders Love Alere Inc (ALR)?
Now, according to many market players, hedge funds are assumed to be bloated, old investment tools of a period lost to current times.
